首页 | 本学科首页   官方微博 | 高级检索  
   检索      

携带人肝细胞生长因子重组质粒pUDK-HGF对大鼠肾纤维化的防治作用
引用本文:陈杏,王汉斌,熊锡山,胡春生,韩媛,卢育新,张庆林,吴祖泽.携带人肝细胞生长因子重组质粒pUDK-HGF对大鼠肾纤维化的防治作用[J].生物技术通讯,2012,23(2):166-170.
作者姓名:陈杏  王汉斌  熊锡山  胡春生  韩媛  卢育新  张庆林  吴祖泽
作者单位:1. 解放军总医院/军医进修学院,北京100853;军事医学科学院附属医院肾内科,北京100071
2. 军事医学科学院附属医院肾内科,北京,100071
3. 军事医学科学院放射与辐射医学研究所,北京,100850
摘    要:目的:研究肝细胞生长因子(HGF)基因转导对庆大霉素诱导的大鼠肾纤维化损伤的防治效果。方法:以雄性Wistar大鼠腹腔注射硫酸庆大霉素注射液制备肾纤维化模型;实验分为正常对照组、肾纤维化模型组、HGF治疗组;造模后第30 d,HGF治疗组于左侧肾脏直接注射重组质粒pUDK-HGF注射液,模型组注射质粒pUDK,正常对照组只进行假手术;于造模后第60 d处死大鼠,评价HGF对血尿素氮、血肌酐、24 h尿蛋白、肾系数等肾功能指标的改善作用,并对肾纤维化进行组织学评价。结果:与正常对照组相比,模型组肾功能下降,肾系数(8.8±0.95 g/kg)、血尿素氮(9.4±2.61 mmol/L)、血肌酐(42±10.33μmol/L,P<0.05)及24 h尿蛋白定量(25.78±8.66 mg,P<0.05)升高;HGF治疗组对肾功能有所改善,可缓解肾纤维化的进展。此外,本实验表明,对已纤维化肾脏直接注射HGF基因,可促进肾间质血管再生,并进一步降低肾小管间质损伤积分。结论:将HGF基因靶向导入大鼠体内可有效防治肾纤维化。

关 键 词:肾纤维化  肝细胞生长因子  靶向治疗

Recombinant Plasmid pUDK-HGF Encoding Human Hepatocyte Growth Factor Gene Retards Renal Fibrosis in Rats
CHEN Xing , WANG Han-Bin , XIONG Xi-Shan , HU Chun-Sheng , HAN Yuan , LU Yu-Xin , ZHANG Qing-Lin , WU Zu-Ze.Recombinant Plasmid pUDK-HGF Encoding Human Hepatocyte Growth Factor Gene Retards Renal Fibrosis in Rats[J].Letters in Biotechnology,2012,23(2):166-170.
Authors:CHEN Xing  WANG Han-Bin  XIONG Xi-Shan  HU Chun-Sheng  HAN Yuan  LU Yu-Xin  ZHANG Qing-Lin  WU Zu-Ze
Institution:1.PLA General Hospital & PLA Postgraduate Medical School, Beijing 100853; 2. Department of Nephrology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071; 3. Beijing Institute of Radiation Medicine, Beijing 100850; China)
Abstract:Objective: To investigate the effects of hepatocyte growth factor(HGF) gene on gentamicininduced re nal fibrosis in rats. Methods: Male Wistar rats were injected gentamicin sulphate intraperitoneally to cause renal fibrosis. All rats were divided into control group, model group, HGF treatment group. On the 30th day after model ing, HGF treatment group animals were transferred pUDKHGF into the left kidney, while those of model group were administered pUDK as an empty plasmid control. The rest were carried out shamoperation. All rats were ex ecuted on the 60th day after modeling. The urine volume and blood samples were used for the determination of se rum creatinine(Scr), blood urea nitrogen(BUN) and 24hurine total protein(24hUTP). The kidneys were excised for histological evaluation and assessment of renal index(RI). Results: Gentamicin caused a reduction in renal function with increasing in RI (8.8+0.95 g/kg), BUN (9.4_+2.61 mmol/L), Scr(42_+ 10.33 Ixmol/L, P〈0.05) and 24hUTP ( 25.78 _+ 8.66 mg, P〈0.05) compared with control group. HGF treatment could improve renal function, then alleviate renal fibrosis. In addition, this study confirmed that HGF could promote angiogenesis and further re duce tubulointerstitial injury. Conclusion: Targeted transfer of HGF gene will ameliorate renal interstitial fibrosis in rats effectively.
Keywords:renal fibrosis  hepatocyte growth factor  targeted therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号